Transparency in drug regulation: public assessment reports in Europe and Australia
Open Access
- 1 November 2016
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 21 (11) , 1806-1813
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Studies using Australia's Pharmaceutical Benefits Scheme data for pharmacoepidemiological research: a systematic review of the published literature (1987-2013)Pharmacoepidemiology and Drug Safety, 2015
- Transparency and the European Medicines Agency — Sharing of Clinical Trial DataNew England Journal of Medicine, 2014
- Improving the Contribution of Regulatory Assessment Reports to Health Technology Assessments—A Collaboration between the European Medicines Agency and the European network for Health Technology AssessmentValue in Health, 2014
- Top 10 drugsAustralian Prescriber, 2013
- Clinical trial transparency: an assessment of the disclosure of results of company-sponsored trials associated with new medicines approved recently in EuropeCurrent Medical Research and Opinion, 2013
- Medical device regulation in Australia: safe and effective?Medical Journal of Australia, 2012
- CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised TrialsPLOS Medicine, 2010
- Is the Internet replacing health professionals? A population survey on sources of medicines information among people with mental disordersSocial Psychiatry and Psychiatric Epidemiology, 2010
- End of contract for Drug and Therapeutics Bulletin : Australian Prescriber was resurrectedBMJ, 2006
- European medicines in the 21st centuryThe Lancet, 1995